Skip to content

Percutaneous Guidewire Placement Syringe 50505

by Dlp, Inc.

510(k) K855089

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK855089 Date18 Feb 1986ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Percutaneous Guidewire Placement Syringe 50505 is a Class II medical device classified under the category of Traditional Wire, Guide, Catheter (DQX). It is designed to assist in the placement of guidewires through percutaneous catheters, facilitating navigation within blood vessels during interventional procedures.

This syringe is intended for single-use in clinical settings and has received FDA 510(k) clearance under the Cardiovascular advisory committee. The device is supplied sterile and is regulated as a substantially equivalent product to a predicate device, with clearance granted on February 18, 1986. No additional regulatory markings or conditions are specified.

Other devices from Dlp, Inc.

See all devices from Dlp, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Percutaneous Guidewire Placement Syringe 50505 primarily used for in medical procedures?

    The Percutaneous Guidewire Placement Syringe 50505 is designed to assist in placing guidewires through percutaneous catheters during interventional procedures. It helps navigate guidewires within blood vessels, ensuring precise and controlled placement for procedures like angioplasty or stenting.

  • Is this syringe intended for reuse in clinical settings, or is it meant for single-use only?

    The device is explicitly labeled for single-use in clinical settings. This ensures patient safety and sterility, as it is supplied sterile and not intended to be reused after one procedure.

  • How is the regulatory status of this syringe determined, and which advisory committee was involved?

    The Percutaneous Guidewire Placement Syringe 50505 received FDA 510(k) clearance under the Cardiovascular advisory committee (CV). It was classified as *substantially equivalent* to a predicate device, meaning its safety and effectiveness were deemed comparable to an already-approved product in the same category (product code DQX).

  • What should clinicians consider when storing this syringe before use?

    Since the syringe is supplied sterile, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures. The packaging should remain intact until immediate use to maintain sterility and prevent contamination.